Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthis Synofzik

Showing results (461-470 of 511) with videos related to

Pageof 52
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 14, 2025
Cross-country variance in facial emotion recognition in presymptomatic and symptomatic behavioral variant frontotemporal dementia: Insights from the GENFI and ReDLat consortiaLiset de Boer, Lize C Jiskoot, Harro Seelaar, et al.
Brain : a Journal of Neurology|April 22, 2025
Disease-modifying effects of TMEM106B in genetic frontotemporal dementia: a longitudinal GENFI studySaira S Mirza, Maurice Pasternak, Andrew D Paterson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 11, 2026
A Severity-Agnostic Atrophy Pattern in Spinocerebellar Ataxia Type 3: Volumetrics from ENIGMA-AtaxiaJason W Robertson, Isaac Adanyeguh, David J Arpin, et al.
Neurology|January 27, 2026
Patterns and Trajectories of Behavioral and Neuropsychiatric Symptoms in Frontotemporal Dementia and Primary Progressive AphasiaLena Marth, Francisco J Martinez-Murcia, Juan-Manuel Górriz-Sáez, et al.
Nature Genetics|March 10, 2015
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathySteffen Syrbe, Ulrike B S Hedrich, Erik Riesch, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2025
Disease stage-specific atrophy markers in Alzheimer's diseaseHannah Baumeister, Helena M Gellersen, Sarah E Polk, et al.
Alzheimer'S Research & Therapy|January 11, 2023
Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE studyFrederic Brosseron, Anne Maass, Luca Kleineidam, et al.
Brain : a Journal of Neurology|July 29, 2022
Neurofilament light levels predict clinical progression and death in multiple system atrophyViorica Chelban, Elham Nikram, Alexandra Perez-Soriano, et al.
Brain : a Journal of Neurology|December 4, 2025
Distinct proteomic CSF profiles in genetic frontotemporal lobar degenerationJulie F H De Houwer, Elise G Dopper, Renee van Buuren, et al.
The Lancet. Neurology|November 9, 2019
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort studyEmma L van der Ende, Lieke H Meeter, Jackie M Poos, et al.
Pageof 52

Showing results (461-470 of 511) with videos related to

Sort By:
Pageof 52
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 14, 2025
Cross-country variance in facial emotion recognition in presymptomatic and symptomatic behavioral variant frontotemporal dementia: Insights from the GENFI and ReDLat consortiaLiset de Boer, Lize C Jiskoot, Harro Seelaar, et al.
Brain : a Journal of Neurology|April 22, 2025
Disease-modifying effects of TMEM106B in genetic frontotemporal dementia: a longitudinal GENFI studySaira S Mirza, Maurice Pasternak, Andrew D Paterson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 11, 2026
A Severity-Agnostic Atrophy Pattern in Spinocerebellar Ataxia Type 3: Volumetrics from ENIGMA-AtaxiaJason W Robertson, Isaac Adanyeguh, David J Arpin, et al.
Neurology|January 27, 2026
Patterns and Trajectories of Behavioral and Neuropsychiatric Symptoms in Frontotemporal Dementia and Primary Progressive AphasiaLena Marth, Francisco J Martinez-Murcia, Juan-Manuel Górriz-Sáez, et al.
Nature Genetics|March 10, 2015
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathySteffen Syrbe, Ulrike B S Hedrich, Erik Riesch, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2025
Disease stage-specific atrophy markers in Alzheimer's diseaseHannah Baumeister, Helena M Gellersen, Sarah E Polk, et al.
Alzheimer'S Research & Therapy|January 11, 2023
Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE studyFrederic Brosseron, Anne Maass, Luca Kleineidam, et al.
Brain : a Journal of Neurology|July 29, 2022
Neurofilament light levels predict clinical progression and death in multiple system atrophyViorica Chelban, Elham Nikram, Alexandra Perez-Soriano, et al.
Brain : a Journal of Neurology|December 4, 2025
Distinct proteomic CSF profiles in genetic frontotemporal lobar degenerationJulie F H De Houwer, Elise G Dopper, Renee van Buuren, et al.
The Lancet. Neurology|November 9, 2019
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort studyEmma L van der Ende, Lieke H Meeter, Jackie M Poos, et al.
Pageof 52